<DOC>
	<DOCNO>NCT01017666</DOCNO>
	<brief_summary>The purpose study understand whether BIIB014 potential affect certain drug break body .</brief_summary>
	<brief_title>BIIB014 Effects Pharmacokinetics ( PK ) Rosiglitazone , Warfarin , Midazolam</brief_title>
	<detailed_description />
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>3- ( 4-amino-3-methylbenzyl ) -7- ( 2-furyl ) -3H- ( 1,2,3 ) triazolo ( 4,5-d ) pyrimidine-5-amine</mesh_term>
	<criteria>Healthy male female subject Between age 18 45 , inclusive . Must body mass index ( BMI ) 19 kg/m2 30 kg/m2 , inclusive Clinically significant abnormality ( determined Investigator ) Other unspecified reason would make subject unsuitable enrollment ( determined Investigator )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Healthy Volunteer</keyword>
</DOC>